On February 14, 2023, Oblato, Inc. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,200 KRW | -1.23% | -1.91% | +64.20% |
1st Jan change | Capi. | |
---|---|---|
+64.20% | 411M | |
+27.42% | 76.68B | |
-0.60% | 24.41B | |
+7.82% | 8.81B | |
+10.46% | 8.48B | |
-25.33% | 7.47B | |
+15.02% | 5.21B | |
+1.24% | 4.12B | |
-8.45% | 3.86B | |
-3.20% | 3.56B |
- Stock Market
- Equities
- A115450 Stock
- News HLB Therapeutics Co.,Ltd.
- Oblato, Inc. announced that it has received KRW 18.408 billion in funding from HLB Therapeutics Co.,Ltd.